GLPG2534
GLPG2534 is an orally active and selective IRAK4 inhibitor, with IC50 values of 6.4 nM and 3.5 nM for human and mouse IRAK4. GLPG2534 can be used for the research of inflammatory skin diseases[1].
Product Specifications
CAS Number
[2095615-97-5]
UNSPSC
12352005
Target
IRAK
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/glpg2534.html
Concentration
10mM
Purity
98.73
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N#CC(C=N1)=CC=C1N2C3=NC(NC4CCOCC4)=C(OCCOCCO)C=C3N=C2
Molecular Formula
C21H24N6O4
Molecular Weight
424.45
References & Citations
[1]Lavazais S, et al. IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases. Sci Transl Med. 2023 Feb 15;15 (683) :eabj3289.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IRAK1; IRAK4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1112127-01 0.02 mg (E-Coli)
Recombinant Sphingomonas wittichii Cobyric acid synthase (cobQ)
Ask
View Details MBS1112127-02 0.02 mg (Yeast)
Recombinant Sphingomonas wittichii Cobyric acid synthase (cobQ)
Ask
View Details MBS1112127-03 0.1 mg (E-Coli)
Recombinant Sphingomonas wittichii Cobyric acid synthase (cobQ)
Ask
View Details 
MBS1112127-04 0.1 mg (Yeast)
Recombinant Sphingomonas wittichii Cobyric acid synthase (cobQ)
Ask
View Details 
MBS1112127-05 0.02 mg (Baculovirus)
Recombinant Sphingomonas wittichii Cobyric acid synthase (cobQ)
Ask
View Details